Elucidating design principles for engineering cell-derived vesicles to inhibit SARS-CoV-2 infection

Mostrar otras versiones (1)

The ability of pathogens to develop drug resistance is a global health challenge. The SARS-CoV-2 virus presents an urgent need wherein several variants of concern resist neutralization by monoclonal antibody therapies and vaccine-induced sera. Decoy nanoparticles—cell-mimicking particles that bind a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunnels, Taylor F., Stranford, Devin M., Mitrut, Roxana E., Kamat, Neha P., Leonard, Joshua N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669840/
https://www.ncbi.nlm.nih.gov/pubmed/34909773
http://dx.doi.org/10.1101/2021.12.04.471153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669840/
https://www.ncbi.nlm.nih.gov/pubmed/34909773
http://dx.doi.org/10.1101/2021.12.04.471153

Ejemplares similares